Company intelligence / Profile preview

Rekovar

Ownership: Private
Development stage: Other

Overview

Rekovar is developing NeoMonki, an investigational wearable device that uses AI analytics to continuously monitor neonates—especially those with NAS—by integrating audio, visual, and physiological data. The goal is to automate assessment and medication dosage delivery for improved individualized care. The product is currently not approved for commercial use and remains under development with NIH funding support.

Therapeutic areas: NeurologyOther
Modalities: DeviceAI-driven monitoring systemWearable technology
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Rekovar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rekovar.

Explore the full profile